Article
Pharma In Brief - Data Protected: "Innovative Drug" Status Prevents Generic NOC
Sanofi-Aventis (Sanofi) markets and sells oxaliplatin, used for the treatment of life-threatening colorectal cancer, in Canada under the brand name ELOXATIN® for use in the treatment of colorectal cancer.
Norton Rose Fulbright Canada LLP
